Amneal Pharmaceuticals, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
AMRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
400 Crossing Boulevard, 3 Rd Floor, Bridgewater, NJ

Insiders trading volume in the past year

Amneal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Tushar Patel 10%+ Owner $221M Nov 7, 2023
Chintu Patel Co-CEO, Director $114M Mar 4, 2024
Dipan Patel Member of 13D Group $111M Nov 7, 2023
Chirag K. Patel President & Co-CEO, Director $99.2M Mar 4, 2024
Tpg Gp A, Llc Former 10% Owner $50.9M Dec 12, 2022
Gautam Patel Director $10.9M May 10, 2024
Tasos Konidaris Executive Vice President & CFO $4.72M Mar 12, 2024
Nikita Shah Executive Vice President $4.72M -$775K -14.1% Aug 14, 2024
Andrew S. Boyer Executive Vice President $4.52M -$491K -9.8% Aug 14, 2024
Paul M. Meister Director $3.86M May 10, 2024
Joseph Todisco Executive Vice President $2.94M May 7, 2022
Jason B. Daly SVP, Chief Legal Officer $2.67M Mar 3, 2024
Gustavo Pesquin Title: Executive Vice President, Chief Commercial Officer - Specialty $2.54M Sep 6, 2022
Ted C. Nark Director $1.6M May 10, 2024
Jeffrey P. George Director $1.43M May 10, 2024
J. Kevin Buchi Director $1.39M May 10, 2024
John Kiely Director $1.36M May 10, 2024
Emily Peterson Alva Director $1.33M May 10, 2024
Shlomo Yanai Director $1.3M May 10, 2024
Deborah M. Autor Director $628K -$256K -29% May 16, 2024

Recent Insider Transactions by Companies or Individuals for Amneal Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.